Perfect Medical Industry Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	737.27	744.16	734.13	677.04	724.61	807.76
Revenue Growth (YoY)	-3.07%	1.36%	8.43%	-6.57%	-10.29%	19.54%
Cost of Revenue	515.46	505.96	533.58	542.63	515.08	555.03
Gross Profit	221.81	238.19	200.56	134.41	209.53	252.73
Selling, General & Admin	131.53	137.56	134.78	123.61	145.44	114.68
Research & Development	11.96	9.3	7.4	7.12	5.58	7.57
Operating Expenses	143.47	146.95	142.2	130.75	151.28	123.02
Operating Income	78.35	91.24	58.36	3.65	58.24	129.71
Interest Expense	-4.69	-3.72	-4.37	-4.46	-2.96	-2.05
Interest & Investment Income	5.14	5.42	3.33	1.03	1.6	2.26
Currency Exchange Gain (Loss)	4.36	13.42	7.34	13.18	3.93	1.9
Other Non Operating Income (Expenses)	3.02	4.9	3.02	3.33	1.52	1.18
EBT Excluding Unusual Items	86.19	111.26	67.67	16.73	62.33	133
Gain (Loss) on Sale of Assets	0.09	0.4	1.19	1.18	0.19	0.44
Asset Writedown	-	-4.28	-14.61	-	-	-
Other Unusual Items	0.08	-	-	0.06	-	-
Pretax Income	86.36	107.38	54.25	17.98	62.52	133.44
Income Tax Expense	13.89	18.26	14.16	3.71	23.75	32.75
Net Income	72.48	89.12	40.09	14.27	38.77	100.69
Net Income to Common	72.48	89.12	40.09	14.27	38.77	100.69
Net Income Growth	3.18%	122.31%	180.93%	-63.20%	-61.49%	176.31%
Shares Outstanding (Basic)	53	49	46	44	41	40
Shares Outstanding (Diluted)	55	51	46	44	41	42
Shares Change (YoY)	18.54%	11.20%	3.98%	8.91%	-2.73%	4.39%
EPS (Basic)	1.37	1.81	0.88	0.32	0.95	2.49
EPS (Diluted)	1.31	1.74	0.87	0.32	0.95	2.40
EPS Growth	-13.25%	100.00%	171.88%	-66.32%	-60.44%	163.82%
Free Cash Flow	22.39	45.84	85.17	52.87	-98.89	0.49
Free Cash Flow Per Share	0.41	0.90	1.85	1.20	-2.43	0.01
Dividend Per Share	0.870	1.500	0.700	0.370	0.316	1.453
Dividend Growth	-34.59%	114.29%	89.19%	17.13%	-78.25%	114.28%
Gross Margin	30.09%	32.01%	27.32%	19.85%	28.92%	31.29%
Operating Margin	10.63%	12.26%	7.95%	0.54%	8.04%	16.06%
Profit Margin	9.83%	11.98%	5.46%	2.11%	5.35%	12.47%
Free Cash Flow Margin	3.04%	6.16%	11.60%	7.81%	-13.65%	0.06%
EBITDA	132.19	141.78	108	51.54	100.5	164.57
EBITDA Margin	17.93%	19.05%	14.71%	7.61%	13.87%	20.37%
D&A For EBITDA	53.84	50.54	49.64	47.89	42.25	34.87
EBIT	78.35	91.24	58.36	3.65	58.24	129.71
EBIT Margin	10.63%	12.26%	7.95%	0.54%	8.04%	16.06%
Effective Tax Rate	16.08%	17.00%	26.11%	20.62%	37.98%	24.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.